- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
Find Winning Strategies to Improving Your Upstream, Downstream Processing, Manufacturing, Formulation and Analytics
What Key Sessions Have the Advisors Chosen for 2012?
Improve the speed, quality and cost of your upstream and cell culture processes with 15+ case studies on: risk mitigation for raw materials and disposables; predictive tools for cell line development; monitoring low level sequence variants and non-antibody production platforms for novel therapies – Genentech, Biogen Idec and Genzyme share their latest findings
Ensure product consistency and in-depth process characterisationwith 5+ data-driven sessions on QbD for mAbs and vaccines; process validation, PAT; high-throughput characterisation technologies and demonstrating comparability - BMS, Eli Lilly, HGS, Novartis, Genentech and Pfizer
Meet the critical CMC, regulatory and development standards needed to bring mAb biosimilars to market in the EU and US with direct feedback from two key BMWP regulators, plus latest from FDA
Identify and evaluate the new downstream technologies driving down production costswith featured sessions on crystallisation, precipitation, updates on affinity ligands, HTPD, plus difficulties developing non-mAb purification platforms – feedback from GSK, MedImmune, Merck Serono, UCL, Bayer, UCA Berkley
Design an effective formulation strategywith detailed discussion and case studies on pre-formulation screening, sub-visible particles, protein aggregation; protein-to-protein interaction and the relationship between charge and viscosity - Genentech, GSK, Boehringer Ingelheim, University of Leiden, Roche, USP and Pfizer
Choice of 5 exciting streams
New Products, New Technologies, New Processes
View the Agenda at a Glance
Learn from Key Experts in the Field of Cell Culture, Downstream, Purification and Analytics
Please Download Brochure for Full List of Speakers
Learn from Key Experts in the Field of Cell Culture, Downstream, Purification and Analytics
Peter O'Callaghan
Category Strategy Manager
Pfizer Biotech, Ireland
|
Claus Tollnick
Head R&D Biologics Center
Sanofi Aventis
|
Peter Kraemer
Head, Engineering Process Development
Sanofi Aventis, Germany
|
Thorsten Peuker
VP, Integrated Solutions
Sartorius Stedim, Germany
|
Nicole Borth
Professor
Natural Resources and Applied Life Sciences, Austria
|
Frantisek Svec
Professor
UCA Berkley, USA
|
Uma Kuchibholta
CSO, Biotherapeutic Lead Optimisation
Eli Lilly, USA
|
Niklas Ekman
Quality Assessor
Finish Medicines Agency, Member of CHMP
|
Dr Karen De Smet
Non-clinical Assessor
FAMHP
|
Peter Kumpalume
Head, Downstream Processing, Biopharm R&D
GSK, UK
|
Dr Bernhard Helk
Section Head Tech Development
Novartis
|
Prof Wim Jiskoot
Drug Delivery Technology
University of Leiden
|
Corporate Sponsors
Associate Sponsors
Supporting Sponsor
Official Registration Desk Sponsor
Sponsors
Featured Exhibitors
Exhibitors
Media Partners
Improve Your Presentation Skills with Our Free Training Course Exclusive to Early Conference Registrants
Book by Friday 27 January to Secure Your Place
Improve Your Presentation Skills at our Day 2 Lunchtime Seminar
Free for early registrants of BPI Europe, this interactive, first-come, first-served basis seminar will equip you with all the key skills needed to create and deliver a successful presentation, ideal for when you return back to the office and report your conference findings to the team. Places are limited so book early to avoid disappointment.
Aims and Objectives
- Planning and writing an effective presentation
- Using visual aids effectively
- Overcoming presentation nerves
- Delivering the presentation confidently
- Answering questions competently
Terms and Conditions apply please download the following form for details: Improve Your Presentation Skills
BRAND NEW TOPICS FOR 2012!
- Risk mitigation strategies for raw materials
- Upstream and downstream challenges for novel therapies
- Biomanufacturing in the face of increased product titres
- New affinity ligands and non-chromographic methods to reduce the cost of downstream purification
- Impact of protein-to-protein interactions on formulations
- Technology transfer of processes, analytical methods and to CMOs
- SME showcase featuring the innovative new companies, products and processes shaping the industry
- Feedback on the recent Process Validation Guideline and companys' struggles to date
Choice of 7 Practical, Expert-Led Workshops
Further details and sample documentation
Pre-Conference Workshops
- Practical Technology Transfer for Biopharmaceuticals (NEW FOR 2012)
- Extractables, Leachables and Particulates - Safety Concerns for Biotechnology Products
- Implementation of Quality by Design (QbD) for Biopharmaceuticals
- Product Characterisation of Biopharmaceuticals for Regulatory Requirements
Post-Conference Workshops
- Understanding Aggregation and Devising Prevention Strategies
- The Current State of Biopharmaceutical Process Validation – New for 2012!
- Developing Strategies for Scaling Up and Other Process Changes
Free downloads From Our 2011 Event
1. Download Johannes Roeber's Fantastically Well Recieved Presentation on The Biosimilars Market at BPI 2011 - Day One Plenary
BioProcessing Professionals Europe:
Join 300+ bioprocesssing professionals operating in the field of upstream, downstream, analytics, formulation and analytics - join today
Reasons why delegates come back year-on-year
"A premium event with good networking and technical updates"
"Great opportunity to network. informative and up-to-date"
"Very good, interesting talks and interactive exhibition"
Feeds | Like | Share    |
Corporate Sponsors
Associate Sponsors
Supporting Sponsors
Founding publication
Latest tweets
